Stock listing

Stuttgart:FLB Standard BioTools Inc. Aktie

German listing (Stuttgart) of Standard BioTools Inc. · home listing NASDAQ:LAB

Follow Standard BioTools Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:LAB

$0.631 USD +0.061 (+10.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LAB

Past year -50.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.573 – $0.650 USDNov 20, 2026
Volume
2.81M sharesNov 20, 2026
Market cap
$249.1M USDAt the close on Nov 20, 2026 · price × 394.7M shares outstanding
52-week range
$0.394 – $1.720 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$811,230 USDMedian day 1.04M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Standard BioTools Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LAB · Home$0.631 USD+0.061 (+10.7%)2,808,206$0.629$0.650$0.573$0.570Close on Nov 20, 2026
Frankfurt:FLB€0.555 EUR+0.040 (+7.8%)—€0.555€0.555€0.555€0.515Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LAB · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.631+0.061+10.7%$0.629$0.650$0.5732,808,206
$0.570+0.031+5.7%$0.550$0.592$0.527697,449
$0.539-0.082-13.1%$0.605$0.624$0.3944,366,184
$0.621-0.086-12.2%$0.701$0.710$0.603639,075
$0.707+0.056+8.6%$0.659$0.735$0.6331,389,947
$0.651+0.008+1.3%$0.652$0.680$0.643365,495
$0.643-0.022-3.3%$0.679$0.715$0.643406,132
$0.665-0.029-4.2%$0.687$0.689$0.655327,234
$0.694+0.058+9.2%$0.637$0.718$0.636730,104
$0.636+0.014+2.2%$0.630$0.644$0.6101,122,557
$0.622+0.006+1.0%$0.628$0.630$0.600918,928
$0.616+0.005+0.9%$0.605$0.630$0.6051,015,170
$0.611+0.001+0.1%$0.610$0.626$0.6001,265,621
$0.6100.0000.0%$0.611$0.628$0.6001,708,226
$0.610-0.010-1.6%$0.622$0.625$0.6001,002,541
$0.6200.0000.0%$0.620$0.630$0.610445,300
$0.6200.0000.0%$0.620$0.630$0.610741,700
$0.620+0.020+3.3%$0.600$0.630$0.5901,037,000
$0.600-0.010-1.6%$0.620$0.620$0.590643,500
$0.610-0.030-4.7%$0.630$0.650$0.590853,000
$0.640-0.010-1.5%$0.630$0.670$0.6301,201,700
$0.650+0.010+1.6%$0.630$0.670$0.630399,600
$0.6400.0000.0%$0.640$0.650$0.620561,400
$0.640+0.010+1.6%$0.620$0.650$0.620414,700
$0.630-0.030-4.5%$0.660$0.660$0.630647,300
$0.660+0.030+4.8%$0.630$0.670$0.630485,700
$0.630-0.030-4.5%$0.640$0.680$0.6301,186,500
$0.6600.0000.0%$0.660$0.670$0.650368,900
$0.660-0.030-4.3%$0.690$0.690$0.650494,600
$0.690+0.020+3.0%$0.680$0.700$0.660649,200
$0.670-0.010-1.5%$0.670$0.680$0.6401,906,400
$0.680-0.040-5.6%$0.710$0.740$0.6801,390,300
$0.720-0.040-5.3%$0.770$0.800$0.7201,397,600
$0.760+0.020+2.7%$0.740$0.800$0.7401,178,400
$0.740+0.010+1.4%$0.730$0.760$0.730786,500
$0.730-0.010-1.4%$0.740$0.750$0.7201,083,100
$0.740+0.030+4.2%$0.720$0.740$0.7101,591,100
$0.710-0.020-2.7%$0.730$0.730$0.710173,400
$0.730-0.010-1.4%$0.750$0.750$0.720479,000
$0.7400.0000.0%$0.740$0.750$0.710471,800
$0.7400.0000.0%$0.740$0.770$0.740743,900
$0.740-0.010-1.3%$0.750$0.770$0.730653,400
$0.750+0.010+1.4%$0.740$0.770$0.7401,346,500
$0.740-0.030-3.9%$0.760$0.760$0.730459,600
$0.770+0.040+5.5%$0.720$0.770$0.7002,694,900
$0.730+0.020+2.8%$0.720$0.750$0.720664,900
$0.710+0.020+2.9%$0.690$0.740$0.690982,300
$0.690-0.010-1.4%$0.680$0.700$0.680841,700
$0.700+0.010+1.4%$0.690$0.710$0.680695,600
$0.6900.0000.0%$0.700$0.700$0.6801,745,600
$0.690-0.040-5.5%$0.710$0.720$0.6801,211,500
$0.730+0.040+5.8%$0.690$0.730$0.6901,946,500
$0.6900.0000.0%$0.700$0.730$0.6702,839,500
$0.690+0.020+3.0%$0.680$0.690$0.6601,763,100
$0.6700.0000.0%$0.680$0.710$0.6602,120,500
$0.670+0.020+3.1%$0.660$0.690$0.6603,077,000
$0.650-0.010-1.5%$0.660$0.660$0.6401,973,100
$0.660+0.020+3.1%$0.650$0.670$0.6401,759,700
$0.640-0.010-1.5%$0.660$0.670$0.6401,260,400
$0.6500.0000.0%$0.660$0.670$0.6401,486,900
$0.6500.0000.0%$0.650$0.660$0.6401,337,300
$0.6500.0000.0%$0.650$0.666$0.6361,306,640
$0.650-0.020-3.0%$0.667$0.699$0.6451,341,616
$0.670+0.020+3.1%$0.630$0.690$0.6303,569,600
$0.650-0.020-3.0%$0.680$0.700$0.6302,009,900
Ticker
Stuttgart:FLB
Asset type
Stock
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All Standard BioTools Inc. news

Standard BioTools Inc. on 6ix

News releases
16 in the last 12 months · 88 in all · newest Nov 19, 2026 · oldest 2020
Calls
17 calls with a replay · 17 with a transcript · latest May 6, 2025
Decks
23 decks · latest Jun 8, 2026

Where Standard BioTools Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:LAB · Home listingNASDAQUnited StatesUSD
BOATS:LABBOATSUnited StatesUSD
gettex:FLBgettexGermanyEUR
LS Exchange:A0RADJLS ExchangeGermanyEUR
Lang & Schwarz:A0RADJLang & SchwarzGermanyEUR
Frankfurt:FLBFrankfurtGermanyEUR
BX Swiss:FLBBX SwissSwitzerlandCHF
Dusseldorf:FLBDusseldorfGermanyEUR
Munich:FLBMunichGermanyEUR
Stuttgart:FLB · This pageStuttgartGermanyEUR
Tradegate:FLBTradegateGermanyEUR

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$185.2M USD
P/E
1.9×
EV/sales
−2.2×
EV/EBITDA
Negative EBITDA
Price/book
0.5×
Gross margin
52.2%
Operating margin
−97.5%
Net margin
157.6%
Debt to equity
0.1×
Beta vs S&P 500
0.67

Forecasts

1 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
1.35 USD · Analysts' mean
EPS, year to Dec 2026
-0.10 · 1 analyst

Team and board

OfficerRole
Michael EgholmPresident and Chief Executive Officer
Alex KimCFO
Sean MacKeyCOO
Standard BioTools’Investor Relations department
Anders DavasSenior Vice President, Global Operations
Betsy JensenChief Human Resources Officer
Mike MusgnugCTO
Sean MacKayChief Business Officer

Events

Calls

CallWhenStatus
Standard BioTools (NASDAQ:LAB) Q1 2025 Earnings CallTue, May 06, 2025 · 4:30 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q4 2024 Earnings CallWed, Feb 26, 2025 · 4:30 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q3 2024 Earnings CallWed, Oct 30, 2024 · 4:30 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q2 2024 Earnings CallWed, Jul 31, 2024 · 4:30 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q1 2024 Earnings CallWed, May 08, 2024 · 4:30 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q4 2023 Earnings CallWed, Feb 28, 2024 · 8:30 AM ETReplay
Standard BioTools (NASDAQ:LAB) Q3 2023 Earnings CallTue, Nov 07, 2023 · 4:30 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q2 2023 Earnings CallTue, Aug 08, 2023 · 5:00 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q1 2023 Earnings CallTue, May 09, 2023 · 5:00 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q4 2022 Earnings CallTue, Feb 14, 2023 · 5:00 PM ETReplay
All 17 calls
CallWhenStatus
Standard BioTools (NASDAQ:LAB) Q3 2022 Earnings CallTue, Nov 08, 2022 · 5:00 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
Standard BioTools (NASDAQ:LAB) Q1 2022 Earnings CallThu, May 05, 2022 · 5:00 PM ETReplay
Fluidigm Corporation (FLDM) Q3 2021 Earnings CallMon, Nov 08, 2021 · 4:30 PM ETReplay
Fluidigm Corporation (FLDM) Q2 2021 Earnings CallThu, Aug 05, 2021 · 5:00 PM ETReplay
Fluidigm Corporation (FLDM) Q1 2021 Earnings CallThu, May 06, 2021 · 5:00 PM ETReplay
Fluidigm Corporation (FLDM) Q4 2020 Earnings CallWed, Feb 10, 2021 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 17, 2026−8.2%
Q2 2026Aug 5, 2026 · After close+2.6%
Q1 2026May 5, 2026 · After close−1.0%
Q4 2025Feb 18, 2026+2.7%
Q3 2025Nov 4, 2025 · After close−4.2%
Q2 2025Aug 11, 2025 · After close+2.3%
Q1 2025May 6, 2025 · After close−3.8%
Q4 2024Feb 26, 2025 · Before open−7.1%
Q3 2024Oct 30, 2024 · After close+4.3%
Q2 2024Jul 31, 2024 · After close−36.6%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+7.6%
Q4 2023Feb 28, 2024 · After close−5.1%
Q3 2023Nov 7, 2023 · After close−4.5%
Q2 2023Aug 8, 2023 · After close+7.6%
Q1 2023May 9, 2023 · After close+12.5%
Q4 2022Feb 14, 2023 · After close+1.4%
Q3 2022Nov 8, 2022 · After close−5.1%
Q2 2022Aug 8, 2022 · After close−17.6%
Q1 2022May 5, 2022 · After close−2.0%
Q4 2021Feb 17, 2022 · After close+7.7%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (June 2026)Merger or acquisition8 slidesJun 8, 2026
Merger or Acquisition (June 2026)Merger or acquisition32 slidesJune 2026
Q1 2025 Earnings PresentationEarnings22 slidesMay 6, 2025
Q4 2024 Earnings PresentationEarnings24 slidesFeb 26, 2025
Investor Presentation (January 2025)Investor deck31 slidesJan 13, 2025
Q3 2024 Earnings PresentationEarnings21 slidesOct 30, 2024
Investor Presentation (September 2024)Investor deck25 slidesSep 5, 2024
Q2 2024 Earnings PresentationEarnings21 slidesJul 31, 2024
Q1 2024 Earnings PresentationEarnings24 slidesMay 8, 2024
Q4 2023 Earnings PresentationEarnings34 slidesFeb 28, 2024
All 23 decks
DeckKindSlidesDate
Investor Presentation (January 2024)Investor deck28 slidesJan 8, 2024
Q3 2023 Earnings PresentationEarnings24 slidesNov 7, 2023
Merger or Acquisition (October 2023)Merger or acquisition15 slidesOct 4, 2023
Q2 2023 Earnings PresentationEarnings26 slidesAug 8, 2023
Q1 2023 Earnings PresentationEarnings19 slidesMay 9, 2023
FY2022 Earnings PresentationEarnings21 slidesFeb 14, 2023
Investor Presentation (January 2023)Investor deck23 slidesJan 9, 2023
Q3 2022 Earnings PresentationEarnings13 slidesNov 8, 2022
Q2 2022 Earnings PresentationEarnings25 slidesAug 8, 2022
Q1 2022 Earnings PresentationEarnings31 slidesMay 5, 2022
Fluidigm — Merger or Acquisition (February 2022)Merger or acquisition21 slidesFeb 14, 2022
Fluidigm — Investor Presentation (January 2017)Investor deck24 slidesJan 9, 2017
Fluidigm — IPO Roadshow (January 2014)IPO roadshow17 slidesJan 29, 2014

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue85.3M91.0M106.3M97.9M130.6M138.1M117.2M113.0M101.9M104.4M
Cost of revenue42.8M46.1M55.9M60.9M53.3M54.8M53.0M51.3M50.0M300.0K
Gross profit42.5M44.9M50.5M37.1M77.3M83.3M64.3M61.6M52.0M58.4M
Research and development26.0M28.8M25.9M37.4M37.9M36.5M31.6M30.0M30.8M38.4M
Selling, general and administrative109.9M103.1M87.5M102.3M98.9M97.9M84.5M79.8M79.5M93.2M
Operating income-110.2M-127.5M-76.6M-116.2M-67.5M-51.0M-51.8M-48.2M-58.4M-73.2M
Depreciation and amortization9.26M12.3M12.7M12.5M3.22M4.01M4.61M5.37M7.41M6.74M
EBITDA-101.0M-115.2M-63.9M-103.8M-64.2M-47.0M-47.2M-42.8M-51.0M-66.5M
Interest expense26.0K3.32M4.57M4.33M3.82M3.57M4.28M13.9M5.82M5.82M
Income before tax-96.7M-90.4M-74.2M-192.9M-63.7M-54.1M-66.7M-61.4M-63.8M-80.2M
Income tax-37.9M542.0K452.0K-2.83M-4.42M-1.08M-1.92M-2.41M-3.26M-4.19M
Net income-74.9M-138.9M-74.7M-190.1M-59.2M-53.0M-64.8M-59.0M-60.5M-76.0M
Earnings per share, basic-0.20-0.52-0.94-2.43-0.78-0.74-0.97-1.49-1.84-2.62
Earnings per share, diluted-0.20-0.52-0.94-2.43-0.78-0.74-0.97-1.49-1.84-2.62

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents120.9M166.7M51.7M81.3M28.5M68.5M21.7M95.4M58.1M35.0M
Short-term investments66.7M126.1M63.2M84.5M0037.0M05.08M24.4M
Receivables13.4M14.7M19.7M17.3M18.3M25.4M19.0M16.7M15.0M14.6M
Inventory20.0M20.7M20.5M21.5M20.8M19.7M13.9M13.0M15.1M20.1M
Current assets454.3M375.9M158.2M208.8M72.1M117.7M96.1M127.1M94.8M96.7M
Property, plant and equipment19.3M22.8M24.2M25.7M28.0M17.5M8.06M8.82M12.3M16.5M
Goodwill111.3M106.3M106.3M106.4M106.6M104.1M104.1M104.1M104.1M
Total assets567.8M612.3M323.1M390.3M275.2M324.8M264.8M303.6M287.4M306.4M
Accounts payable5.41M5.05M9.24M7.91M10.6M9.22M5.15M4.03M4.21M3.97M
Current liabilities108.3M65.9M109.3M43.4M49.6M54.2M32.8M37.6M33.5M29.5M
Long-term debt299.0K299.0K3.98M62.8M64.2M54.2M53.8M172.1M195.2M195.0M
Total debt30.8M299.0K63.5M64.9M111.6M95.4M60.0M172.1M195.2M195.0M
Total liabilities143.5M140.6M159.9M160.5M180.6M185.7M111.2M231.5M256.4M253.2M
Shareholders' equity424.3M471.7M-148.1M-81.5M94.6M139.1M153.6M72.1M30.9M53.2M
Shares outstanding386.4M377.5M80.2M79.5M76.9M74.5M70.0M49.3M38.8M29.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-74.3M-143.5M-43.3M-89.4M-44.1M-15.4M-35.2M-25.2M-24.1M-39.1M
Capital spending-8.30M-8.36M-2.83M-3.83M-13.3M-12.7M-2.53M-372.0K-1.57M-5.07M
Free cash flow-82.6M-151.8M-46.1M-93.2M-57.3M-28.1M-37.7M-25.6M-25.7M-44.2M
Cash from investing27.4M363.2M20.2M-88.1M-11.9M40.0M-39.3M4.72M17.7M45.1M
Cash from financing570.0K-102.6M-6.81M230.8M16.0M20.9M2.79M57.7M29.0M116.0K
Dividends paid-299.0K-1.50M
Share buybacks0-40.5M-5.41M-563.0K0-459.0K-629.0K60.9M29.1M-111.0K
Change in cash-45.5M116.3M-29.8M52.9M-40.1M45.8M-71.7M37.3M23.0M5.93M

Open Financials

Filings

FilingDateTypeFiled with
425Nov 19, 2026Other filingsSEC
8-K · Current reportNov 19, 2026Management or board changeSEC
425Nov 16, 2026Other filingsSEC
8-K · Current reportNov 16, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
10-Q · Quarterly reportNov 3, 2026Quarterly reportSEC
425Nov 3, 2026Other filingsSEC
8-K · Current reportNov 3, 2026Current reportSEC
424B3 · ProspectusOct 30, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
EFFECT · Notice that a registration is effectiveOct 22, 2026Other filingsSEC
424B3 · ProspectusOct 21, 2026Offer documentSEC
S-4/A · Registration statement, amendedOct 21, 2026Offer documentSEC
S-4/A · Registration statement, amendedOct 9, 2026Offer documentSEC
425Oct 5, 2026Other filingsSEC
8-K · Current reportOct 5, 2026Current reportSEC
425Sep 30, 2026Other filingsSEC
8-K · Current reportSep 30, 2026Material contractSEC
S-4/A · Registration statement, amendedSep 9, 2026Offer documentSEC
4 · Change in ownershipAug 24, 2026Insider tradeSEC
4 · Change in ownershipAug 24, 2026Insider tradeSEC
4 · Change in ownershipAug 24, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansAug 5, 2026Offer documentSEC
S-8 · Registration statement for employee plansAug 5, 2026Offer documentSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026ResultsSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 30, 2026Big-stake noticeSEC
425Jul 29, 2026Other filingsSEC
8-K/A · Current report, amendedJul 29, 2026Current reportSEC
425Jul 28, 2026Other filingsSEC
425Jul 28, 2026Other filingsSEC
8-K · Current reportJul 28, 2026Material contractSEC
4 · Change in ownershipJul 27, 2026Insider tradeSEC
8-K · Current reportJul 24, 2026Current reportSEC
425Jul 20, 2026Other filingsSEC
S-4 · Registration statementJul 20, 2026Offer documentSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
8-K · Current reportJun 18, 2026Management or board changeSEC
SCHEDULE 13D · Big-stake noticeJun 12, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 9, 2026Big-stake noticeSEC
425Jun 8, 2026Other filingsSEC
8-K · Current reportJun 8, 2026Material contractSEC
8-K · Current reportJun 5, 2026Current reportSEC
8-K · Current reportJun 3, 2026Management or board changeSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
8-K · Current reportMay 28, 2026Management or board changeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 5, 2026ResultsSEC
ARS · Annual report to shareholdersApr 27, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 27, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 27, 2026Meeting noticeSEC
8-K · Current reportApr 24, 2026Current reportSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
10-K · Annual reportMar 16, 2026Annual reportSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
8-K · Current reportFeb 24, 2026ResultsSEC
8-K/A · Current report, amendedFeb 5, 2026Current reportSEC
8-K · Current reportJan 30, 2026ResultsSEC
8-K · Current reportJan 8, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeJan 7, 2026Big-stake noticeSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 28, 2025Big-stake noticeSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
10-Q · Quarterly reportNov 4, 2025Quarterly reportSEC
8-K · Current reportNov 4, 2025ResultsSEC
8-K · Current reportSep 17, 2025Current reportSEC
4 · Change in ownershipSep 11, 2025Insider tradeSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
8-K · Current reportSep 3, 2025Current reportSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
S-8 · Registration statement for employee plansAug 15, 2025Offer documentSEC
10-Q · Quarterly reportAug 15, 2025Quarterly reportSEC
NT 10-Q · Late filing noticeAug 11, 2025Explanation requestSEC
8-K · Current reportAug 11, 2025ResultsSEC
4 · Change in ownershipAug 5, 2025Insider tradeSEC
4 · Change in ownershipAug 5, 2025Insider tradeSEC
8-K · Current reportAug 1, 2025Management or board changeSEC
4/A · Change in ownership, amendedJul 30, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
4 · Change in ownershipJun 24, 2025Insider tradeSEC
8-K · Current reportJun 23, 2025Material contractSEC
8-K · Current reportJun 20, 2025Management or board changeSEC
SD · Specialized disclosureJun 2, 2025ESG reportSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
144 · Notice of proposed saleMay 23, 2025Other filingsSEC
144 · Notice of proposed saleMay 23, 2025Other filingsSEC
144 · Notice of proposed saleMay 23, 2025Other filingsSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
144 · Notice of proposed saleMay 22, 2025Other filingsSEC
144 · Notice of proposed saleMay 22, 2025Other filingsSEC
144 · Notice of proposed saleMay 22, 2025Other filingsSEC
144 · Notice of proposed saleMay 21, 2025Other filingsSEC
144 · Notice of proposed saleMay 21, 2025Other filingsSEC
144 · Notice of proposed saleMay 21, 2025Other filingsSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025ResultsSEC
ARS · Annual report to shareholdersApr 30, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 30, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
4 · Change in ownershipMar 24, 2025Insider tradeSEC
10-K · Annual reportMar 10, 2025Annual reportSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 4, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 4, 2025Big-stake noticeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
8-K · Current reportFeb 26, 2025ResultsSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025ResultsSEC
8-K · Current reportJan 10, 2025Management or board changeSEC
8-K · Current reportDec 20, 2024Current reportSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
144 · Notice of proposed saleNov 12, 2024Other filingsSEC
SC 13G · Big-stake noticeNov 8, 2024Big-stake noticeSEC
8-K · Current reportNov 7, 2024Management or board changeSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
8-K · Current reportOct 30, 2024ResultsSEC
SC 13G · Big-stake noticeOct 24, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 21, 2024Big-stake noticeSEC
144 · Notice of proposed saleSep 9, 2024Other filingsSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
8-K · Current reportSep 5, 2024Current reportSEC
3 · Initial statement of ownershipSep 3, 2024Insider tradeSEC
8-K · Current reportAug 30, 2024Management or board changeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 26, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
4 · Change in ownershipAug 16, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedAug 14, 2024Big-stake noticeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 6, 2024Insider tradeSEC
S-8 · Registration statement for employee plansAug 6, 2024Offer documentSEC
10-Q · Quarterly reportAug 6, 2024Quarterly reportSEC
8-K · Current reportJul 31, 2024Management or board changeSEC
8-K · Current reportJul 31, 2024ResultsSEC
4 · Change in ownershipJul 23, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
8-K · Current reportJul 1, 2024Management or board changeSEC
EFFECT · Notice that a registration is effectiveJun 28, 2024Other filingsSEC
3 · Initial statement of ownershipJun 26, 2024Insider tradeSEC
CORRESP · Letter to the SECJun 25, 2024Other filingsSEC

This page holds 200 of 1,005 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Standard BioTools Inc.’s releases

Common shares
394,711,296
Fully diluted
394,711,296

Fully diluted

LineShares
Common shares394,711,296

Share count over time

CountShares
Nov 22, 2026394,711,296

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Casdin Capital, LLC88.8M22.6%US$65.8MSep 30, 2026
Viking Global Investors LP58.7M14.9%US$43.4MSep 30, 2026
Long Focus Capital Management, LLC25.3M6.4%US$18.7MSep 30, 2026
Mak Capital One LLC25M6.4%US$18.5MSep 30, 2026
Vanguard15.1M3.9%US$11.2MSep 30, 2026
BlackRock8.26M2.1%US$6.11MSep 30, 2026
Hollow Brook Wealth Management LLC5.2M1.3%US$3.85MSep 30, 2026
Qube Research & Technologies Ltd4.94M1.3%US$3.66MSep 30, 2026
Neuberger Berman Group LLC4.35M1.1%US$3.21MSep 30, 2026
D. E. Shaw & Co., Inc.4.04M1.0%US$2.99MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Geode Capital3.56M0.91%US$2.64MSep 30, 2026
Tikvah Management LLC3.55M0.90%US$2.63MSep 30, 2026
Arrowstreet Capital, Limited Partnership3.37M0.86%US$2.5MSep 30, 2026
Gsa Capital Partners LLP3.03M0.77%US$2.25MSep 30, 2026
Morgan Stanley2.78M0.71%US$2.06MSep 30, 2026
Citadel2.57M0.65%US$1.9MSep 30, 2026
Peapod Lane Capital LLC2.25M0.57%US$1.67MSep 30, 2026
Jacobs Levy Equity Management, Inc2.21M0.56%US$1.63MSep 30, 2026
Mink Brook Asset Management LLC2.19M0.56%US$1.62MSep 30, 2026
Renaissance Technologies2.04M0.52%US$1.51MSep 30, 2026
Marshall Wace, LLP2.03M0.52%US$1.51MSep 30, 2026
Acadian Asset Management LLC1.51M0.39%US$1.12MSep 30, 2026
Schwab1.47M0.38%US$1.09MSep 30, 2026
State Street1.46M0.37%US$1.08MSep 30, 2026
Loews Corp1.25M0.32%US$926KSep 30, 2026
Two Sigma1.2M0.31%US$889KSep 30, 2026
Man Group plc1.08M0.28%US$803KSep 30, 2026
Schonfeld Strategic Advisors LLC962K0.24%US$712KSep 30, 2026
Staley Capital Advisers Inc900K0.23%US$667KSep 30, 2026
Jane Street715K0.18%US$529KSep 30, 2026
Northern Trust698K0.18%US$517KSep 30, 2026
Rockefeller Capital Management L.P.579K0.15%US$429KSep 30, 2026
Next Capital Management LLC546K0.14%US$404KSep 30, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.533K0.14%US$394KSep 30, 2026
Millennium532K0.14%US$394KSep 30, 2026
CPP Investments473K0.12%US$350KSep 30, 2026
HighTower Advisors, LLC461K0.12%US$341KSep 30, 2026
Intellectus Partners, LLC405K0.10%US$300KSep 30, 2026
Susquehanna384K0.10%US$285KSep 30, 2026
Invesco378K0.10%US$280KSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.340K0.09%US$252KSep 30, 2026
Amova Asset Management Americas, Inc.340K0.09%US$251KSep 30, 2026
Oppenheimer & Co Inc327K0.08%US$242KSep 30, 2026
Johnson & Johnson312K0.08%US$231KSep 30, 2026
WINTON GROUP Ltd288K0.07%US$214KSep 30, 2026
Bank of America255K0.06%US$188KSep 30, 2026
State of Wyoming246K0.06%US$182KSep 30, 2026
J. Goldman & Co LP226K0.06%US$167KSep 30, 2026
Jain Global LLC222K0.06%US$165KSep 30, 2026
Goldman Sachs204K0.05%US$151KSep 30, 2026

This page holds 50 of 100 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund8.43M2.1%US$6.94MJun 30, 2026
Vanguard Extended Market Index Fund3.42M0.87%US$2.81MJun 30, 2026
iShares Biotechnology ETF2.65M0.67%US$2.18MJun 30, 2026
Vanguard Russell 2000 Index Fund1.48M0.38%US$1.7MMay 31, 2026
Schwab U.S. Small-Cap ETF1.43M0.36%US$1.64MMay 31, 2026
Fidelity Extended Market Index Fund1.26M0.32%US$1.44MMay 31, 2026
Royce Micro-Cap Fund1.25M0.32%US$1.03MJun 30, 2026
Neuberger Intrinsic Value Fund1.04M0.26%US$1.19MMay 31, 2026
Vanguard Health Care Index Fund741K0.19%US$852KMay 31, 2026
Inception Portfolio655K0.17%US$539KJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Fidelity Total Market Index Fund546K0.14%US$628KMay 31, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio504K0.13%US$414KJun 30, 2026
Fidelity Series Total Market Index Fund460K0.12%US$529KMay 31, 2026
Royce Capital Fund - Micro-Cap Portfolio406K0.10%US$334KJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF334K0.09%US$275KJun 30, 2026
Column Small Cap Select Fund305K0.08%US$351KMay 31, 2026
Fidelity Nasdaq Composite Index Fund254K0.06%US$292KMay 31, 2026
Vanguard Russell 2000 Value Index Fund221K0.06%US$255KMay 31, 2026
Schwab U.S. Broad Market ETF181K0.05%US$209KMay 31, 2026
Global X Genomics & Biotechnology ETF171K0.04%US$196KMay 31, 2026
Fidelity ZERO Total Market Index Fund164K0.04%US$143KJul 31, 2026
Vanguard Institutional Total Stock Market Index Fund158K0.04%US$130KJun 30, 2026
Schwab Total Stock Market Index Fund150K0.04%US$130KJul 31, 2026
Morgan Stanley Pathway Small-Mid Cap Equity ETF142K0.04%US$163KMay 31, 2026
Vanguard Balanced Index Fund140K0.04%US$115KJun 30, 2026
Tarkio Fund139K0.04%US$159KMay 31, 2026
Vanguard Growth And Income Fund135K0.03%US$111KJun 30, 2026
Invesco RAFI US 1500 Small-Mid ETF130K0.03%US$113KJul 31, 2026
Bridge Builder Small/Mid Cap Value Fund128K0.03%US$105KJun 30, 2026
Small Cap Index Fund114K0.03%US$131KMay 31, 2026
Fidelity ZERO Extended Market Index Fund113K0.03%US$98,101Jul 31, 2026
Strategic Advisers U.S. Total Stock Fund111K0.03%US$128KMay 31, 2026
U.S. Small Cap Equity Fund87,3710.02%US$75,838Jul 31, 2026
Goldman Sachs Absolute Return Tracker Fund87,1820.02%US$71,725Jun 30, 2026
Invesco NASDAQ Future Gen 200 ETF68,0000.02%US$78,200May 31, 2026
Column Small Cap Fund52,1280.01%US$59,947May 31, 2026
Fidelity Flex Small Cap Index Fund50,5260.01%US$43,857Jul 31, 2026
Siit Extended Market Index Fund49,6000.01%US$57,040May 31, 2026
Victory Extended Market Index Fund43,4050.01%US$37,676Jul 31, 2026
VIP Extended Market Index Portfolio26,805<0.01%US$22,052Jun 30, 2026
Vanguard Russell 3000 Index Fund21,308<0.01%US$24,504May 31, 2026
iShares MSCI World Small-Cap ETF18,450<0.01%US$21,218May 31, 2026
ProShares Russell 2000 High Income ETF13,531<0.01%US$15,561May 31, 2026
ProShares UltraPro Russell200010,704<0.01%US$12,310May 31, 2026
ProShares Ultra Russell200010,582<0.01%US$12,169May 31, 2026
Corgi Genomics & Precision Medicine ETF8,547<0.01%US$7,032Jun 30, 2026
Total Stock Market Index Trust7,423<0.01%US$6,107Jun 30, 2026
VIP Total Market Index Portfolio7,294<0.01%US$6,001Jun 30, 2026
Destinations Small-Mid Cap Equity Fund7,257<0.01%US$8,346May 31, 2026
State Street Balanced Index Fund2,078<0.01%US$1,710Jun 30, 2026

This page holds 50 of 52 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Eli Casdin23.90%93.8MJun 6, 2026Schedule 13D
Viking Global Investors LP15.00%58.7MJun 6, 2026Schedule 13D
MAK Capital Fund LP6.30%25MSep 30, 2026Schedule 13G
Long Focus Capital Management, LLC6.00%23.5MJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Eli Casdin
Other companies: GeneDx Holdings Corp. (Board Member · Since at least Apr 27, 2022); 2Seventy Bio Inc (Director · Mar 20, 2024 – May 13, 2025 · Past); EQRx Inc (Director · Sep 30, 2022 – Sep 30, 2022 · Past); Tenaya Therapeutics, Inc. (Director · Jun 10, 2022 – Nov 17, 2022 · Past); Century Therapeutics, Inc. (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Absci Corporation (Director · Jun 8, 2022 – Jun 8, 2022 · Past)
Director · Since at least Apr 4, 2022
Carlos Paya
Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least May 15, 2025); Vaxcyte, Inc. (President, Immune Design Corp Chairman, Vaxcyte · Since at least Oct 27, 2021); Mallinckrodt Inc (Director · May 22, 2019 – Jun 16, 2022 · Past); Immune Design Corp (President and CEO, Director · Oct 30, 2015 – Apr 2, 2019 · Past)
Director · Mar 23, 2017 – Jun 14, 2023 · Past
Evan Jones
Other companies: Veracyte, Inc. (Board Member · Since at least Oct 29, 2013); CapForce Inc. (Director · May 4, 2015 – May 17, 2021 · Past); Foundation Medicine Inc (Director · Sep 24, 2013 – Jul 31, 2018 · Past); CAS Medical Systems Inc (Director · Jun 20, 2012 – Jun 24, 2013 · Past)
Director · Dec 12, 2011 – Jul 31, 2017 · Past
Frank R. Witney
Other companies: Alamar Biosciences, Inc. (Director · Since at least Apr 16, 2026); Cerus Corporation (Director · Since at least May 9, 2024); Revvity, Inc. (Director · Since at least May 1, 2024); Telesis Bio, Inc. (Director · Jul 6, 2023 – Jul 6, 2023 · Past)
Director · Since at least Jun 28, 2024
Kathy L Hibbs
Other companies: Sophia Genetics SA (Director · Since at least Mar 18, 2026); 23Andme Holding Co (Chief Administrative Officer · Jun 16, 2021 – May 20, 2024 · Past); Genomic Health Inc (SVP & General Counsel · Jul 26, 2012 – Feb 15, 2014 · Past)
Director · Since at least Jan 5, 2024
Laura Clague
Other companies: Travere Therapeutics, Inc. (Chief Financial Officer · Nov 17, 2014 – May 10, 2022 · Past); Turtle Beach Corporation (Director · Aug 23, 2010 – Aug 23, 2010 · Past); Genasys Inc. (Director · Dec 8, 2008 – Apr 27, 2022 · Past)
Director · Oct 30, 2018 – Jun 14, 2023 · Past
Nicolas M. Barthelemy
Other companies: Repligen Corporation (Director · Since at least May 11, 2016); 908 Devices Inc. (Director · Dec 17, 2020 – Jun 15, 2022 · Past); Twist Bioscience Corporation (Director · Oct 24, 2019 – Nov 21, 2022 · Past)
Director · Mar 23, 2017 – Apr 1, 2022 · Past
John A Young
Other companies: Affymetrix Inc (Director · Nov 8, 2006 – Jun 17, 2009 · Past); Aspira Women's Health Inc. (Director · Jan 21, 2006 – Oct 28, 2008 · Past)
Director · Feb 9, 2011 – Jul 31, 2017 · Past
Troy Cox
Other companies: MapLight Therapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jun 23, 2026); Sophia Genetics SA (Board Member and Lead Independent Director · Since at least Jun 10, 2026)
Director · Since at least Jun 18, 2026
Jeffrey G Black
Other companies: Exagen Inc. (Chief Financial Officer · Since at least Sep 1, 2024)
SVP & Chief Financial Officer · May 15, 2024 – Aug 20, 2024 · Past
All 31 people
PersonSeat
Jennifer Ling Lee
Other companies: Moderna, Inc. (Chief Accounting Officer · Dec 7, 2018 – Mar 9, 2020 · Past)
See Remarks · May 18, 2016 – Feb 20, 2018 · Past
Thomas D Carey
Other companies: EXACT Sciences Corporation (Director · Apr 29, 2013 – Jun 2, 2021 · Past)
Director · Since at least Jan 5, 2024
Alex KimCFO · Since at least Nov 4, 2025
Ana K StankovicDirector · Dec 15, 2020 – May 25, 2021 · Past
Anders DavasSenior Vice President, Global Operations · Since at least Nov 5, 2026
Betsy JensenChief Human Resources Officer · Since at least Nov 5, 2026
Bill ColstonDirector · Jun 15, 2022 – Jun 15, 2022 · Past
Colin McCrackenChief Commercial Officer · Apr 30, 2019 – Feb 22, 2022 · Past
Gajus Vincent WorthingtonCHIEF EXECUTIVE OFFICER, Director · May 20, 2016 – Aug 22, 2016 · Past
Hanjoon Alex KimChief Financial Officer · Since at least Apr 4, 2022
Jeremy Steven DavisSVP Chief Commercial Officer · Apr 4, 2022 – Feb 21, 2023 · Past
Mai Chan YowSee Remarks · Feb 17, 2012 – Feb 20, 2018 · Past
Marc UngerEVP, R&D and Marketing · Aug 6, 2015 – Aug 22, 2016 · Past
Michael EgholmPresident & CEO, Director · Since at least Apr 4, 2025
Mike MusgnugCTO · Since at least Nov 4, 2026
Robert C JonesSee Remarks · May 20, 2016 – Aug 22, 2016 · Past
Sean MacKaySVP & Chief Business Officer · Since at least May 21, 2025
Sean MacKeyCOO · Since at least Nov 4, 2026
Standard BioTools’Investor Relations department · Since at least Nov 3, 2026
Vikram JogChief Financial Officer · Sep 20, 2017 – Feb 21, 2023 · Past
William Maxwell SmithEVP, Legal Affairs · Oct 10, 2011 – Jun 20, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Standard BioTools Inc.